|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4436727A
(en)
|
1982-05-26 |
1984-03-13 |
Ribi Immunochem Research, Inc. |
Refined detoxified endotoxin product
|
|
US4866034A
(en)
|
1982-05-26 |
1989-09-12 |
Ribi Immunochem Research Inc. |
Refined detoxified endotoxin
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
FI861417A0
(fi)
|
1985-04-15 |
1986-04-01 |
Endotronics Inc |
Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
|
|
US5374548A
(en)
|
1986-05-02 |
1994-12-20 |
Genentech, Inc. |
Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
|
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4877611A
(en)
|
1986-04-15 |
1989-10-31 |
Ribi Immunochem Research Inc. |
Vaccine containing tumor antigens and adjuvants
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
EP1088830A3
(en)
|
1987-06-22 |
2004-04-07 |
Medeva Holdings B.V. |
Hepatitis b surface antigen particles
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
WO1990006951A1
(en)
|
1988-12-16 |
1990-06-28 |
De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Pneumolysin mutants and pneumococcal vaccines made therefrom
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
EP0414374B1
(en)
|
1989-07-25 |
1997-10-08 |
Smithkline Biologicals S.A. |
Novel antigens and methods for their preparation
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
EP1167379A3
(en)
|
1994-07-15 |
2004-09-08 |
University Of Iowa Research Foundation |
Immunomodulatory oligonucleotides
|
|
JP3958360B2
(ja)
|
1995-02-24 |
2007-08-15 |
キャンタブ ファーマシューティカルズ リサーチ リミティド |
免疫治療剤として役立つポリペプチド及びポリペプチド調製の方法
|
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
US5843464A
(en)
|
1995-06-02 |
1998-12-01 |
The Ohio State University |
Synthetic chimeric fimbrin peptides
|
|
US7341727B1
(en)
|
1996-05-03 |
2008-03-11 |
Emergent Product Development Gaithersburg Inc. |
M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
|
|
US5856462A
(en)
|
1996-09-10 |
1999-01-05 |
Hybridon Incorporated |
Oligonucleotides having modified CpG dinucleosides
|
|
EP0998557A2
(en)
|
1997-07-21 |
2000-05-10 |
North American Vaccine, Inc. |
Modified immunogenic pneumolysin, compositions and their use as vaccines
|
|
GB9727262D0
(en)
|
1997-12-24 |
1998-02-25 |
Smithkline Beecham Biolog |
Vaccine
|
|
WO1999052549A1
(en)
|
1998-04-09 |
1999-10-21 |
Smithkline Beecham Biologicals S.A. |
Adjuvant compositions
|
|
AU2001255196A1
(en)
|
2000-03-29 |
2001-10-08 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing immunogenicity of antigens
|
|
CN101888856B
(zh)
|
2007-11-07 |
2014-08-27 |
塞尔德克斯医疗公司 |
结合人树突和上皮细胞205(dec-205)的抗体
|
|
US12297266B2
(en)
|
2016-04-18 |
2025-05-13 |
Celldex Therapeutics, Inc. |
Agonistic antibodies that bind human CD40 and uses thereof
|
|
TWI796329B
(zh)
*
|
2017-04-07 |
2023-03-21 |
美商默沙東有限責任公司 |
抗－ilt4抗體及抗原結合片段
|
|
WO2019148412A1
(en)
*
|
2018-02-01 |
2019-08-08 |
Merck Sharp & Dohme Corp. |
Anti-pd-1/lag3 bispecific antibodies
|
|
US20210301020A1
(en)
*
|
2018-07-24 |
2021-09-30 |
Amgen Inc. |
Combination of lilrb1/2 pathway inhibitors and pd-1 pathway inhibitors
|
|
EP4003523A4
(en)
*
|
2019-07-30 |
2023-09-06 |
Merck Sharp & Dohme LLC |
ANTI-PD-1/LAG3/TIGIT TRISPECIFIC ANTIBODIES AND ANTI-PD-1/LAG3 BISPECIFIC ANTIBODIES
|
|
US20230058779A1
(en)
*
|
2020-01-02 |
2023-02-23 |
Merck Sharp & Dohme Llc |
Combination cancer treatment using a pd-1 antagonist, an ilt4 antagonist, and lenvatinib or salts thereof
|
|
MY209480A
(en)
*
|
2020-05-01 |
2025-07-11 |
Ngm Biopharmaceuticals Inc |
Ilt-binding agents and methods of use thereof
|
|
CA3214853A1
(en)
*
|
2021-04-09 |
2022-10-13 |
Celidex Therapeutics, Inc. |
Antibodies against ilt4, bispecific anti-ilt4/pd-l1 antibody and uses thereof
|